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Abstract 
Background: The prescribing rates of psychotropic medication for foster children far exceed the 
prescribing rates of psychotropic medications for other children, ages 0-18. Many psychotropic 
medications have not been researched for children and have not been proven safe or effective for 
this age group, and do not adhere to AACAP safety guidelines.  
Objectives: The purpose of this integrative literature review is to identify the factors that 
contribute to the high prescribing rates of psychotropic medication among foster children, as well 
as identifying the risks associated with prescribing habits that do not follow AACAP guidelines. 
Additionally, safer alternatives to psychotropic medications will be assessed.  
Methods: An integrative literature review was conducted following the Whittemore & Knafl 
guideline. Databases searched included: CINAHL, ProQuest Nursing, PubMed, ProQuest 
Sociology, and PsycINFO. Included articles were related to foster children, ages 0-18, and were 
published between 2008-2018. Eighteen articles were selected for review.  
Results: Trends that are correlated with high prescribing rates were based on demographics, 
diagnosis, prescriber and medication type, and fragmented care. Additionally, the risks 
associated with prescribing habits that do not follow AACAP guidelines were: polypharmacy, 
exorbitant and off label antipsychotic use, receiving a treatment plan that does not follow 
evidence-based practice, and receiving medication before proper mental health screenings were 
completed. Furthermore, alternative options that can limit the amount of psychotropic 
medications prescribed and better ensure medication safety are: psychosocial treatment, 
treatment foster care, and the “Fostering Healthy Futures” program. 
Conclusion: Psychotropic medications are being prescribed without utilizing the AACAP 
protocols effectively. Additionally, safer first line treatments, such as psychological therapy, 
could be used in place of medications to increase safety and decrease negative long-term effects 
for foster children who are prescribed psychotropic medication. 
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  Introduction 
Background and Significance 
 Foster care is a growing phenomenon in the United States. According to the Adoption 
and Foster Care Analysis and Reporting System (2014), in the year 2014, an estimated 415,129 
children in the U.S., ages 0-18, were part of the foster care system.  The American Academy of 
Child and Adolescent Psychiatry (AACAP) lists several reasons why a child would be placed in 
foster care, such as a child being abused, neglected, or abandoned by his parents (AACAP, 
2015). Trends have shown increasing numbers of children in the foster system over the last three 
years and fewer adoptions (Davenport, 2015). Transferring a child into foster care puts the child 
under tremendous stress and this stress is compounded by the trauma endured from possible 
abuse in the child’s previous home (AACAP, 2015).  
 Psychotropic medications, also known as psychoactive medications, are drugs that affect 
a person’s emotions, thoughts, and behaviors (Scott, 2009). The word psychotropic comes from 
the Greek words “psycho” and “trop”, which literally translate to turning the mind, because that 
is what these medications are intended to do (Online Etymology Dictionary, 2017). Psychiatric 
disorders cause there to be too much or too little transmission of a specific neurotransmitter in 
the brain. Psychotropic drugs operate by activating a neurotransmitter that will either inhibit or 
potentiate an electrical impulse to correct the existing imbalance. The main categories of 
psychoactive medications are antidepressants, mood stabilizers, psychostimulants, antianxiety 
drugs, and antipsychotic drugs (Scott, 2009). 
 The U.S. Government Accountability Office (GAO) released a report in 2011 after 
auditing the trends of prescribing psychoactive drugs to foster children, ages 0-18, in five states 
INAPPROPRIATELY MEDICATING FOSTER CHILDREN 4 
(Lord, 2014). The audit uncovered that foster children were being prescribed psychotropic 
medications at an average rate that was 4.5 times higher than their peers. The report also found 
that thousands of foster children across the U.S. were prescribed more than five psychotropic 
medications concurrently, with no evidence supporting this method of treatment. In fact, 
polypharmacy increases both adverse and long-term effects of treatment, as well as making it 
difficult to discern which medication is responsible for positive outcomes. Additionally, the 
report uncovered that thousands of foster children were prescribed psychotropic medications at 
amounts that surpassed the FDA approved doses. Furthermore, the report indicated that 6.5% of 
foster children were prescribed antipsychotic medication, which is an extremely potent group of 
medications with severe side effects. The average age of the children taking antipsychotics was 
between 6-11 years old, and many antipsychotics have not been proven safe or effective for 
children. (Lord, 2014). 
In the last 20 years, foster care has grown 65% (Steele & Buchi, 2008). One study found 
that 71% of foster children were given psychotropic medication compared to 3.9% of youth in 
the general population (Warner, Song, & Pottick, 2014). Zito et al. (2008) found 72.5% of foster 
youth were taking psychotropic medications, while dosReis et al. (2011) found the prevalence of 
psychotropic medication use can be as high as 77% among foster youth. These rates highlight a 
steadily increasing trend in prescribing psychotropic medication to the foster population, yet 
studies lack evidence of the effectiveness of the treatment regimens and disregarded safety 
concerns, especially in an adolescent population (Steele & Buchi, 2008). 
 The AACAP created protocols to ensure the proper prescribing of psychotropic drugs for 
foster children (Lee, Foras, & Brown, 2015). The first requirement outlined is that after a child is 
removed from his home, he is required to receive a mental health screening and assessment to 
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determine if any trauma treatment is necessary. If psychotropic drugs are utilized for treatment, a 
psychiatric evaluation must be done. Additionally, all stakeholders must be informed about the 
medication plan, be part of the decision-making process, and the responsible stakeholder must 
consent to the medication and the minor must assent to it. The prescribing physician must then 
establish guidelines for the medication use and monitor the medications effect over time.  While 
it is the intention of many physicians and caseworkers to be constantly active in the medicating 
process, heavy caseloads and time limits often prevent adequate monitoring and joint planning. 
Additionally, there are currently no requirements for medication training in a regular foster care 
home, and the physician has no obligation to provide further resources for foster parents to 
understand medication regimens (Lee, Foras, & Brown, 2015). 
Despite the AACAP guidelines, higher rates of mental disorders and prescribing of 
psychotropic medication creates a major risk for the foster population (Lord, 2014). While all 
medications have side effects, the risks and potential adverse effects of psychotropic medication 
in the adolescent population is not well understood. It is evident that foster children are 
prescribed medications much more than the general population. It is unclear if there is proper 
understanding and adherence to the medication regimen or if the types, dosages, number of 
concurrent medications, and ages at which foster children begin taking psychotropic medications 
are safe or the best course of treatment (Lord, 2014).  
Purpose Statement 
 The purpose of this integrative literature review is to better understand the factors 
associated with over-prescription of psychotropic medications to foster children as defined by the 
AACAP guidelines and to ascertain what risks are associated with high prescribing rates. 
Additionally, this review will determine alternative treatments to remedy this growing problem. 
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Research Questions 
The following research questions will guide this study: 
1. What factors contribute to high prescribing rates of psychotropic medications among 
foster children? 
2. What risks are associated with prescribing psychotropic medication to foster children that 
do not follow AACAP guidelines? 
3. What alternatives to psychotropic medications can effectively manage mental illness in 
foster children? 
Conceptual Framework 
 The conceptual framework for this paper is Neuman’s system model. This model focuses 
on how a person responds to stressors in his or her environment, which is referred to as an open 
system. Biological, mental, environmental, sociocultural, developmental, and spiritual factors are 
all interrelated pieces that compose the system. A healthy individual can adapt to stressors in any 
of these capacities. The system model is therefore considered a holistic model of care (Neuman, 
& Fawcett, 2011). 
 In Neuman’s model, the basic functions of life, such as genetic structure and baseline 
physiology, are at the center of the circle. Concentric circles around the core called lines of 
resistance (LOR) are factors that protect a person against stress. The outermost circle is called 
the flexible line of defense (FLD) and just within that circle is the normal line of defense (NLD). 
The FLD acts as a first line barrier against the stressors and the more flexibility that the line has, 
the less the stress will affect a person. The NLD represents a person’s normal healthy state, and it 
is not good at shielding against stress. The NLD indicates the stability of the system. When both 
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lines of defense are broken, the lines of resistance are relied upon to protect an individual from 
harm. The LOR utilizes a variety of internal and external factors to support the NLD and return 
the individual to a healthy state. Neuman’s system model is guided by prevention, and nurses can 
use primary, secondary, and tertiary prevention to help patients adapt to stress. Primary 
prevention creates a more flexible FLD by reducing stress risk factors. Secondary prevention is 
used when the NLD is breached by stress and the tension must be diagnosed and treated. Lastly, 
tertiary prevention focuses on adapting and finding stability after a stressful period.  The system 
model is depicted in Figure 1 (Neuman, & Fawcett, 2011). 
 Foster children are in a very high stress system. Each stressor the children encounter 
weakens their lines of defense and leaves them vulnerable. A break in the system from 
environmental stressors seems to affect the psychological variable most often in foster children. 
Interventions such as therapy could act as a primary prevention strategy by educating foster 
children about healthy coping mechanisms and managing stressors to strengthen weakened lines 
of defense. With secondary prevention, damage has already been done to the system and the 
focus is on ensuring that the damage to the system does not reach the core. At this point, 
medication may be necessary. It is possible that utilizing more primary prevention for children in 
foster care could limit the need for medication, as well as limiting the severity of damage to 
child’s system from stress. 
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Figure 1. The Neuman system model (Neuman, 2011). 
Methods 
Research Design 
 An integrative literature review was conducted to address the research questions 
proposed in this study. The review analyzes and comprehensively summarizes the selected 
sample of studies to create a picture of the overuse of psychotropic medication for the foster 
youth population. Both quantitative and qualitative studies are included in the review. This 
literature review will help nurses gain a better understanding of the issue at hand and advocate 
for the best interest of their patients who meet these criteria. 
Literature Search Strategies 
 A computerized search was completed utilizing several databases, including the 
Cumulative Index to Nursing and Health Literature (CINAHL), PsycInfo, ProQuest Nursing and 
Allied Health Source, ProQuest Sociology Collection, and PubMed. Searches were done on these 
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databases with a variety of combinations of key words which included foster children, foster 
system, foster care, foster parents, foster home care, psychotropic drugs, psychotropic 
medications, hypnotics, antianxiety agents, tranquilizing agents, antipsychotics, and 
antidepressive agents. The word foster was searched with the limiter of subject heading to ensure 
that the subjects in the selected articles are part of the foster system. 
Literature Search Limitations and Inclusion/ Exclusion Criteria 
 Articles used in this literature review include those relating to children in the foster care 
system, ages 0-18. Furthermore, articles are connected to the keywords used in the database 
search; however, to ensure the database search isolates the most relevant results, the word foster 
will be required to be a major subject heading for the search criteria. Additional inclusion criteria 
are that the article is peer reviewed, written in English, identified as a research or journal article, 
is a primary source, is published after the year 2008, is a quantitative or qualitative study, and 
that the study is done in the U.S. The articles that met these criteria were read and evaluated for 
use on an individual basis. Articles were excluded if the research participants were not specified 
as foster children, if the study was done in a language other than English, if the article was a 
literature review or case study, if the article was written before 2008, if participants were 
primarily over 18 years old, or if the study was pertaining to foster care outside of the U.S. Of 
the 6,402 articles identifies in the databases using key word searches, eighteen articles were 
selected after determining that all inclusion and exclusion criteria were met. Table 1 depicts the 
way the articles were selected based on the inclusion and exclusion criteria listed above.  
Data Synthesis and Analysis 
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 Eighteen articles were included in the literature review. All articles included outcomes of 
foster children who were prescribed psychotropic medication. Data synthesis and analysis was 
done with the framework of Whittemore and Knafl (2005). Each article was individually 
reviewed for related content and divided into subgroups to further facilitate the analysis for data 
reduction. Data was congregated and exhibited based on variables, such as the author, year 
written, sample, alternative treatments, and results. Data is displayed in a matrix for clear 
comparison of all variables. Data comparison was done to find themes and answer the proposed 
research questions. Table 2 lists selected articles in a clear way for data analysis. 
Results 
The results are categorized based on the proposed research questions. The first section 
will highlight trends that are correlated with high prescribing rates, such as demographics, 
diagnosis, prescriber and medication type, and fragmented care. The second section will analyze 
the risks associated with prescribing habits that do not follow AACAP guidelines, such as 
polypharmacy, exorbitant and off label antipsychotic use, receiving a treatment plan that does 
not follow evidence-based practice, and receiving medication before proper mental health 
screenings and diagnosis are completed. The final section will consider alternative options that 
can be utilized to limit the amount of psychotropic medication prescribed and can better ensure 
medication safety, such as psychosocial treatment, treatment foster care, and the “fostering 
healthy futures” program. 
Factors Associated with Prescribing Trends 
Demographics. White, male children, on the older end of the spectrum were found to be 
the most likely to be prescribed a psychoactive medication and were most likely to struggle 
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behaviorally (Raghavan, Lama, Kohl & Hamilton, 2010; Steele & Buchi, 2008; Warner, Song, & 
Pottick, 2014). Moreover, Zito et al. (2008) found that white males between the ages 10-14 were 
most likely to be prescribed psychotropic medication and Brenner et al. (2014) found that 6-12-
year olds had highest medication use. Medication rates were found to be higher among Medicaid 
insured foster children and varied depending on demographic location, drastically differing from 
state to state (Warner, Song, & Pottick, 2014). One study found that predictors were more 
location based then individual or diagnosis based (Raghavan, Lama, Kohl & Hamilton, 2010), 
Urban areas have a higher incidence of psychotropic medication oversight (Mackie et al., 2011) 
and the southwest states have highest prevalence of prescribing psychotropic medication (Zito et 
al., 2008). Other studies found that symptoms were the greatest predictor of prescribing rates 
(Brenner et al., 2014).   
Diagnosis. While the high prescribing rates of psychotropic medications may be part of a 
growing trend of physicians prescribing more over the past 10 years, the high rates of 
psychotropic use among the foster population is also due to the prevalence of behavioral and 
emotional issues consistent in this population (Mackie et al., 2011). Zito et al. (2008) found that 
of the children being treated with psychotropic medication, 39% of kids were being treated for 
ADHD, 36% for depression, 34% for anxiety, and, 21% for conduct disorders, and 17% for 
bipolar disorder. Raghavan & McMillen (2008) found that 45% of foster children were 
diagnosed with at least one DSM IV diagnosis. The most common diagnoses among foster 
children receiving psychotropic medication was ADHD (55%) followed by anxiety (52%) 
(Linares, Martinez- Martin, & Castellanos, 2013).  
Provider and Medication Type. Zito et al. (2008) found that in a general random 
sample of children in foster care, psychiatrists prescribed 93% of psychotropic meds to foster 
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children, as opposed to primary care providers (PCP). Zito et al. (2008) also found that 
psychiatrists are more likely to prescribe antipsychotics and lithium then antidepressants and 
anxiolytics like PCP’s. Alternatively, Brenner et al. (2014) found that foster children are more 
often prescribed psychotropic medication from a non-psychiatrist. Brenner et al. (2014) and 
Raghavan & McMillen (2008) found that antidepressants were the most common medication 
prescribed, comprising 67% of the psychotropic medications, whereas Linares, Martinez- Martin, 
& Castellanos (2013) found that the most common medication prescribed was stimulants (69%) 
followed by atypical antipsychotics at (65%).  The most common combination of medications 
was antidepressants and antipsychotics (Raghavan & McMillen, 2008).  
Fragmented Care. One cause of high prescribing rates of psychotropic medication for 
children in foster care is discontinuity of care (Fontanella, Gupta, Hiance-Steelesmith, & 
Valentine, 2015). Limited access to quality care, frequently changing guardianship, and 
providers being unable to access medical charts were the primary barriers that led to fragmented 
care in this population (Steele & Buchi, 2008). Having a constant source of care, having a 
relationship with the same provider time after time, having an individualized plan of care, having 
a reliable source to monitor treatment outcomes are all important factors in ensuring proper, safe 
and effective treatment (Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015). Foster 
children rarely have continuity of care, and frequent disruptions in care can risk adherence to 
already complex medication routines, as well as monitoring for adverse reactions to medication 
(Warner, Song, & Pottick, 2014). Because of a lack of continuous care, many foster children do 
not get the required mental health screenings and do not have sufficient primary care, which is 
the first barrier of defense when it comes to consistently monitoring treatment plans (Fontanella, 
Gupta, Hiance-Steelesmith, & Valentine, 2015). Fragmented care also jeopardizes proper 
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medication reconciliation which can lead to patients receiving multiple psychotropic medications 
in the same class (Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015). Additionally, 
some foster parents were told that their foster child had a mental health condition but were not 
able to obtain resources or appointments for several months (Hayes, Geiger, & Lietz, 2015). 
Fontanella, Gupta, Hiance-Steelesmith, & Valentine (2015) found that of 93.6% of foster 
children who were diagnosed with bipolar disorder, only 46% had regular outpatient visits and 
more than 31% of the sample had a gap in care of 60 days or more. Another sample showed that 
more than half of foster children with severe emotional disorders taking psychotropic medication 
did not receive monthly outpatient treatments, which is considered a minimal requirement of care 
(Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015).  Moreover, continuity of care is 
associated with positive effects such as improved health outcomes, increased medication 
adherence, improved preventative care, decreased emergency and hospital visits and lower 
expenditures (Fontanella, Gupta, Hiance-Steelesmith, & Valentine, 2015). 
Risks Associated with Non-Protocol Prescribing  
Polypharmacy. Psychotropic polypharmacy is described as taking three or more 
psychotropic medications concurrently (Rubin et al., 2012). Polypharmacy is more prevalent 
among foster youth then the general population (Warner, Song, & Pottick, 2014). In 2008, 
Raghavan & McMillen found that the prevalence of polypharmacy was 10% among foster 
children, while Brenner et al. (2014) found that the rate of polypharmacy was 25%, and Mackie 
et al. (2011) found that 41.3% of foster youth exhibited polypharmacy. Rubin et al. (2012) found 
that 20% of those who displayed polypharmacy were taking multiple medications in the same 
drug class. For those receiving 5 or more psychotropic medications, antipsychotics were the most 
common concomitantly prescribed drug (Zito et al., 2008).  
INAPPROPRIATELY MEDICATING FOSTER CHILDREN 14 
 Antipsychotic Use.  Rubin et al., (2012) found that 10% of foster children were taking 
antipsychotics, while Zito et al., (2008) found that 22% were taking antipsychotics. 
Antipsychotics are mainly used to treat schizophrenia, bipolar, and autism disorders, however 
antipsychotics are prescribed most often to foster children for off label uses (Rubin et al., 2012). 
dosReis et al., (2011) found that, 53% of foster children taking antipsychotic medications were 
prescribed the medication as a treatment for ADHD and 34% for the treatment of depression, 
which are off label uses. Also, psychotropic medications are being prescribed to foster children 
at increasing rates to treat disruptive behaviors (Rubin et al., 2012). dosReis et al., (2011), 
Raghavan & McMillen, (2008), and Rubin et al., (2012) found that nearly all the antipsychotics 
prescribed were second generation antipsychotics, also known as atypical antipsychotics. Second 
generation antipsychotics are strongly linked to adverse metabolic effects, such as the 
development of type 2 diabetes, dyslipidemia, and weight gain (Cohen, Lacasse, Duan & 
Sengelmann, 2013; dosReis et al., 2011; Rubin et al., 2012), as well as pathological cholesterol 
changes, and negative effects in the cardiac and neurologic systems (Cohen, Lacasse, Duan & 
Sengelmann, 2013). Children were discovered to develop these metabolic disorders in relation to 
atypical antipsychotics 5.1 times more often than the adult population (dosReis et al., 2011). 
Additionally, despite the lack of evidence to suggest the efficacy of polypharmacy or analyze the 
risks that may come with it, more than 38% of foster children were concomitantly prescribed an 
additional psychotropic medication together with their antipsychotic medication (dosReis et al., 
2011). Finally, over 20% of the children in foster care taking antipsychotics were prescribed 
more than one antipsychotic medication concurrently (Rubin et al., 2012). 
Lack of Evidence Based Practice. Even though many foster children have mental health 
needs, very few receive treatment formulated with evidence-based practice, which includes 
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training children and parents to understand negative side effects of medication, proper 
medication administration, and to ensuring that each child receives a full mental health 
evaluation with an accurate diagnosis before prescribing medication (Scozzaro & Janikowski, 
2015).  There is limited evidence regarding the effectiveness of psychotropic medication among 
foster children, with complete disregard for functional outcomes, potential for long term 
durability, and the safety consequences of the treatment regimen for the children (Cohen, 
Lacasse, Duan & Sengelmann, 2013). Zito et al. (2008) found that all the atypical antipsychotics 
used by the children in the study were utilized for off label uses without approval from the FDA 
for dosage and indication in this age group and that 74% of SSRI being prescribed were not 
approved for adolescents and children. Linares, Martinez- Martin, & Castellanos (2013) found 
that antipsychotic medications are often combined with stimulant medications to treat ADHD 
and to treat aggressive behavior although it has not been approved for this population. Brenner et 
al. (2014) found that 7% of children 0-5 in his study were receiving psychotropic medications, 
despite regulations stating that children of this age group should not be prescribed any 
psychotropic medication at all. Additionally, using more than two antipsychotic medications 
concurrently is not an evidenced based practice and it increases the risk of adverse effects, yet 
20% of people taking antipsychotics were taking more than one drug in the same class (Rubin et 
al., 2012). Also, despite evidence-based practice suggesting monthly psychiatric visits while 
taking psychotropic drugs, only 42% of adolescents stated that they had seen a psychiatrist in last 
two months (Brenner et al., 2014). More than 50% of people taking a psychotropic medication 
were not seeing a psychologist or receiving adjunct social service treatment, as evidence based 
practice suggests (Brenner et al., 2014).  
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 Lack of Appropriate Screening. Children in foster care are more likely to have mental 
health care needs which is why more emphasis needs to be placed on ensuring timely mental 
health evaluations at the time children enter care, following the recommendation of the American 
Academy of Pediatrics and the Child Welfare League of America (Steele & Buchi, 2008). It is 
essential that all children get screened for mental illness because there is a proven correlation 
between being part of a traumatic event, like abuse, and having traumatic symptoms that are 
indicative of mental illness (Griffin et al., 2011). Almost 80% of foster children have significant 
emotional and behavioral problems, as well as being eight times more likely than their peers to 
be hospitalized for a psychiatric disorder (Williams & Sherr, 2009). Foster children were 
reported to be diagnosed with mental health conditions ten times more than other children in the 
Medicaid system, and receiving a proper mental health screening increased the likelihood of 
proper medication and psychosocial treatment following evidenced based practice (Steele & 
Buchi, 2008). Receiving medication oversight and extra services such as case management, 
social services, school services, outpatient treatment, and psychiatric visits were highly 
correlated with number of medications prescribed and increased with each additional medication 
(Brenner et al, 2014). One study found that more than half of foster children that participated did 
not receive a mental health evaluation (dosReis et al., 2011). 
Alternative/Safer Treatment Options 
 Psychosocial Treatment. Children in foster care use mental health services at a rate 20 
times that the general population (Linares, Martinez- Martin, & Castellanos, 2013). More than 
50% of the children in foster care have some type of emotional or behavioral problem, but only 
55% of those children receive mental health services and treatment that follow national standards 
(dosReis et al., 2011; Scozzaro & Janikowski, 2015). Despite several organizations creating 
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standards of care for medicating foster children, few state and county health administrators stated 
that they knew that these standards existed (Warner, Song, & Pottick, 2014). According to the 
standards of care psychotropic medication should not be provided before foster children begin 
counseling and psychotherapy, and once the child begins therapy the therapy should continue 
concurrently with the medication treatment (Scozzaro & Janikowski, 2015). For 50% of foster 
care children, psychotropic medication was the sole treatment for their mental health issues, 
lacking any adjunct psychosocial treatment (Warner, Song, & Pottick, 2014). A study found that 
only 33% of the children who were given psychotropic medication received behavioral health 
care along with it (Mackie et al., 2011; Scozzaro & Janikowski, 2015). Fontanella, Gupta, 
Hiance-Steelesmith, & Valentine (2015) found that 30% of children who required mental health 
services received none during a yearlong period. Taussig & Culhane (2010) found that within a 
group of foster children, 42% met diagnostic criteria for a DSM diagnosis and 57% met criteria 
for a mental health disorder, yet most of the children in the study did not receive any 
psychosocial therapy (Hayes, Geiger, & Lietz, 2015). Warner, Song, & Pottick (2014) found that 
only 10% of youth in foster care being treated with psychotropic medication received concurrent 
individualized therapy and only 5% received behavioral therapy. Foster parents stated that they 
were concerned when Medicaid would only approve 4-8 sessions for children to resolve serious 
emotional and behavioral issues, and many were told that if they want any behavioral counseling 
that they would likely have to pay out of pocket (Hayes, Geiger, & Lietz, 2015). One study 
found that the only trauma related diagnosis in the DSM is PTSD, so children with lesser trauma 
symptoms either get overtreated or not treated at all (Griffin et al., 2011). Better practice to treat 
trauma symptoms would be to help the children develop more strengths and protective factors 
INAPPROPRIATELY MEDICATING FOSTER CHILDREN 18 
against trauma, to focus less on treatment with medications, and focus more on risk behaviors, 
safety, and support (Griffin et al., 2011).  
Psychosocial treatment may be effective as sole first line treatment for moderate mental 
health issues. Williams & Sherr (2009) found that psychosocial treatment was equally as 
effective for treating foster children with severe emotional and behavioral issues as it is in 
treating the general population despite its limited use, and that therapy was more effective when 
focusing on the child’s strength (Williams & Sherr, 2009).  
Treatment Foster Care. Treatment foster care (TFC) is a community based intensive 
treatment intervention for foster children with emotional, behavior, and mental health problems 
(Brenner et al., 2014). In TFC, “treatment foster parents” work as primary caregivers who obtain 
more training and ensure more supervision of treatments then regular foster parents (Brenner et 
al., 2014). Brenner et al. (2014) conducted a study and found that 59% of children in TFC take 
psychotropic medication. For foster children with severe behavioral issues, treatment foster care 
was found to be more effective at treatment, reducing criminal actions, and ensuring adjunct 
treatment and services (Robst, Armstrong, & Dollard, 2011). 
Fostering Healthy Futures. Fostering Healthy Futures (FHF) is a program that 
combines skills group and mentoring to achieve better self-esteem, social support, social 
acceptance, and coping skills for foster children that were abused. In a randomized controlled 
trial, it was concluded that 9 months of treatment at FHF significantly reduced mental health 
symptoms in the children that participated. There was a decrease in symptoms of anxiety, 
depression, suicidality, and trauma, and the children had improved quality of life. After the 
program, children were less likely to need mental health therapy or psychotropic medication. The 
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trial proved that a good skills training curriculum with evidenced based practice was effective at 
reducing risk and promoting health (Taussig & Culhane, 2010). 
Discussion 
 It was unanimously concluded across all the articles that were reviewed that psychotropic 
medications are prescribed at higher rates for foster children than the general population. This 
poses several safety concerns, especially with medications that are considered high risk 
medications, such as antipsychotics, and when polypharmacy is involved, as each comes with 
serious adverse effects. It is also unsettling that many of the medications prescribed are not 
approved for children or for the indicated reason that they were being prescribed. Furthermore, 
prescribing rates were found to be erratic and vary based on demographics. Prescribing rates 
should not only be lower but should also be consistent and based solely on symptomology and 
diagnosis. A 2006 report from the Government Accountability Office (GAO) stated that 1 in 3 
states recognized the use of psychotropic medication by the foster population to be among the 
most pressing issues in the child welfare system (Rubin et al., 2012). 
Another issue with the hasty prescribing of medications is that foster advocates do not 
feel that they were able to participate in treatment planning and education, which is a protocol 
outlined by the AACAP. A survey found that 48% of foster parents were not included in the 
treatment planning for their kids, despite being responsible for ensuring the child follows the 
treatment regimen and felt that physicians often prescribed medications in place of trying to get 
to the root of mental health issues (Hayes, Geiger, & Lietz, 2015). Many parents consulted the 
internet, friends, and social workers to gain information about treatment that should have been 
explained by the provider. Foster parents have reported wanting more decision-making power in 
their children’s care, being their advocate (Hayes, Geiger, & Lietz, 2015). 
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Additionally, it seems that despite numerous organizations aside from the AACAP 
attempting to create safety standards for psychotropic medication use among children in foster 
care, such as the American Academy of Pediatrics and the Child Welfare League of America, 
there is limited evidence that these guidelines are used in practice (Steele and Buchi, 2008; 
Williams & Sherr, 2009). A study found that 47.9% of states endorsed that there should be a 
state policy about foster children receiving a mental health evaluation (Mackie et al., 2011). 
54.2% of states specified that they had policies about psychotropic medication, but 30.4% of 
these policies were only regarding a subpopulation of children 6 years and younger (Mackie et 
al, 2011). Only 2 states have specific policies against high risk medications like antipsychotics 
(Mackie et al, 2011). 26.9% of states said that they had a policy regarding polypharmacy 
(Mackie et al, 2011). Shockingly, only 29% of welfare agencies stated that they had policies 
about psychotropic medication monitoring and oversight (Mackie et al, 2011). Perhaps it is not 
that more policies are needed to regulate the use of psychotropic drugs, rather a more unified set 
of guidelines with higher utilization and enforcement rates. 
Moreover, regardless of the frequent attempts to create effective policy, one of the most 
effective strategies for reducing the high prescribing rates may be through education. A blind 
trial was done to determine if an educational session with current literature about psychotropic 
medication would affect the habits and attitudes of prescribers and advocates regarding 
psychoactive medication given to foster children. The results were that prescriptions for 
psychoactive drugs from prescribers and advocates that attended the seminar immediately 
decreased and continued to decrease for 7 months after the information session, dropping by 
nearly 20% (Cohen, Lacasse, Duan & Sengelmann, 2013). 
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One unexpected finding was that one of the ways that psychotropic medication was not 
used according to protocol was that in some studies psychotropic medication was under 
prescribed to foster children who were given a DSM diagnosis that qualified them for medical 
treatment. Undertreatment was found to be an issue with 41% of people who met diagnostic 
criteria for medical treatment of ADHD and 19% who met criteria for depression, yet they were 
not prescribed any medication for it (Raghavan & McMillen, 2008). 
The safer treatments such as psychosocial and behavioral therapy, should be used as first 
line treatment for foster children and should continue as adjunct therapy even if it is determined 
that medical treatment is necessary. Using psychoactive drugs to treat children should be avoided 
unless all evidenced based practices, such as psychosocial treatments, have been expended, a 
benefit versus risk analysis for the psychotropic medication comes out in favor of the benefit, the 
prescriber of the medication is aware of all the effects of the medications, and close observation 
of the child taking the medication is verified. 
Limitations 
 There were several limitations to this review paper. Many of the papers reviewed for this 
article obtained research based on Medicaid reports which were lacking in certain data points 
leaving important variables unknown, like the accuracy of DSM diagnoses used to prescribe 
psychotropic medication and what medications the children were on before entering foster care. 
Also, the Medicaid reports were not verified by the foster children or parents who were included 
in the report, so adherence and understanding of the medication regimen were often unknown. 
Additionally, finding and relevant studies proved difficult because of the sensitive nature of the 
subjects and because of a lack of available research on the topic. Furthermore, it was difficult to 
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comprehensively conclude long term effects because of a lack of long term studies among the 
foster population.  
Suggestions for future research 
Due to the overwhelming results that prove that there is an issue with prescribing 
psychotropic medication to children in foster care that is not complicit with AACAP guidelines, 
it is imperative that future research is determine ways to minimize the improper prescribing of 
psychotropic medications. Ideas for future research would be to continue to follow prescribing 
trends of psychotropic medications, to assess long term functional outcomes of psychotropic 
treatment with and without adjunct psychosocial therapy, to do a longitudinal study to determine 
if psychotropic medication is effective long term or if it is ineffective and discontinued, to 
determine foster children with continuous care receive less medications then those with 
fragmented care, to assess polypharmacy trends with psychotropic medication, to asses 
prescribing habits among different providers to determine the factors that lead to demographic 
based medication trends, and to determine the efficacy of psychotropic medications that are 
currently being used without FDA approval. Additionally, it is important to determine which 
medications and doses can safely be given to children, and to research how much foster children 
and foster parents understand about their medication regimens and if they accurately follow 
them. 
Implications for nursing 
As nurses, we are bound by the principles of beneficence and non-maleficence. It is our 
duty to ensure that the patients that we treat are benefiting from our treatment and that the value 
of the treatment outweighs the risks associated with it. We must ensure that protocol is being 
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followed and that foster children receive timely mental health evaluations. Furthermore, any 
opportunity to educate families about psychotropic medications, their adverse effects, and proper 
administration should be done. Primary prevention of stressors should be utilized whenever 
possible, and when medication is utilized, nurses should help ensure that there is proper 
medication oversight. Additionally, as first line advocates, it is our duty to represent vulnerable 
populations, like foster children, and advocate on their behalf to prescribing physicians, policy 
makers, and legislators, to enlighten them about the needs of the population. Nurses in contact 
with foster children should advocate for psychosocial and behavioral treatment, as well as 
reducing the amount of psychotropic medication prescribed and the duration of time that children 
remain on those medications. Lastly, it is important to aid foster parents in understanding the 
Medicaid system to ensure that effective continuous care is obtained for their children.  
Conclusion 
This review was done because the trend of inappropriately prescribing psychotropic medications 
to foster children poses a serious threat to a vulnerable population. This review helps determine 
factors related to high prescribing rates of psychotropic medications, expose the risks related to 
improper prescribing of psychotropic medication, and outline alternative treatment methods for 
nurses and healthcare workers to consider in the future. Potential implications of this review are 
that standardized medication safety procedures may be updated and alternative treatments to 
medication may be utilized as fist line treatment for mental disorders in foster children. 
Additionally, this review may highlight the need for more oversight and guardian education 
about psychotropic medication. 
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Appendices 
Preliminary Data Search 
Table 1: Table of study selection and review process. 
Number of 
studies found 
using 
keywords 
CINAHL 
N= 118 
Psychinfo 
N=249 
PubMed 
N=481 
ProQuest 
Nursing 
N= 4286 
ProQuest 
Sociology 
N=1268 
Number of 
Studies 
meeting 
inclusive 
criteria 
20 11 11 37 36 
Number of 
studies after 
using 
exclusion 
criteria 
10 
 
4 6 6 27 
Number of 
studies after 
excluding 
duplicates 
9 1 3 2 3 
Total Selected articles: 18 
Data Matrix  
Table 2: Data summary of included articles. 
Source Sample  Method Concepts Measured Alternative 
Interventions 
Results 
Brenner, 
Southerland
, Burns, 
Wagner, & 
Farmer, 
2014 
247 
foster 
children 
(14 
Treatm
ent 
Foster 
Homes)  
 
Randomi
zed trial 
• Treatment 
foster care 
• Psychotropic 
medication 
• Polypharmac
y 
• Psychosocial 
therapy 
Randomized 
test trial of 
Treatment 
Foster Care 
Agencies 
A high 
correlation 
between 
mental health 
symptoms and 
psychotropic 
treatment and a 
high rate of 
polypharmacy 
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Warner, 
Song, & 
Pottick, 
2014 
1,722 
foster 
children 
Survey • Mental 
health 
services 
• Psychotropic 
medication 
• Primary 
intervention 
• Adjunct 
therapy 
• Continuity of 
care 
Outpatient 
mental health 
survey 
Among foster 
children 
presenting 
problems 
predicted 
psychotropic 
treatment 
Rubin, 
Matone, 
Huang, 
dosReis, 
Feudtner, & 
Localio, 
2012 
686,080 
foster 
children 
(based 
on 
Medicai
d files) 
Data 
analysis 
with 
logistical 
regressio
n 
• Polypharmac
y 
• Antipsychoti
cs 
• Psychotropic 
treatment 
• Medicaid 
• Evidence 
based 
practice 
Prescriptions 
filled 
Use of 
antipsychotics 
and 
polypharmacy 
have increased 
Mackie et 
al., 2011 
58 
(inform
ants) 
Cross 
sectional 
national 
study 
• Psychotropic 
medication 
policy 
• Medication 
oversight 
• Mental 
health 
evaluation 
• Medication 
consent 
• Polypharmac
y 
• antipsychotic
s 
Interviews, 
document 
review, and 
census 
review 
Psychotropic 
medication 
policy varies 
by state if it 
exists at all. 
Most are rarely 
followed 
Scozzaro & 
Janikowski, 
2015 
200 
(case 
files) in 
Northea
st 
county 
Case file 
analysis 
• Demographic
s 
• Mental 
health 
• Behavioral 
therapy 
• Psychotropic 
therapy 
• Mental 
health 
Case file 
review 
Foster children 
have higher 
rate of mental 
health 
diagnosis as 
well as 
psychotropic 
medication and 
behavioral 
therapy 
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screening 
and diagnosis 
• Evidence 
based 
practice 
• Adjunct 
therapy 
Fontanella, 
Gupta, 
Hiance-
Steelesmith, 
& 
Valentine, 
2015 
952 
foster 
youth 
Longitudi
nal 
cohort 
study 
• continuity of 
care 
• serious 
emotional 
disturbance 
• bipolar and 
schizophreni
a patients 
• lack of 
screening 
 
Outpatient 
psychosocial 
and medical 
treatment 
Less than half 
sample 
received 
regular 
outpatient 
services- 
discontinuous 
care 
Zito et al., 
2008 
472 
foster 
youth in 
southw
est 
states 
Random 
sample 
Medicaid 
data 
analysis 
• Medicaid 
• Psychotropic 
monotherapy 
• Adjunct 
therapy 
• Mental 
health 
disorders 
• Polypharmac
y 
• Antipsychoti
cs 
• Drugs by 
class 
• Demographic
s 
• prescribers 
Assessment 
of Medicaid 
data 
Foster children 
receive 
psychotropic 
treatment and 
polypharmacy 
at much higher 
rate than 
general 
population 
Cohen, 
Lacasse, 
Duan, & 
Sengelman
n, 2013 
4,000 
prescrib
ers and 
advocat
es 
Blind 
trial 
• Child welfare 
workers 
• Education 
• Alternative 
treatments 
• Evidence 
based 
practice 
Educational 
information 
on 
psychotropic
s 
(CriticalThin
kRX 
seminar) 
Education 
seminar 
decreased 
prescription of 
psychotropics 
Raghavan, 
Lama, Kohl 
5,501 
foster 
Cross 
sectional 
• Psychotropic 
trends 
National 
Survey of 
Child 
characteristics 
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& 
Hamilton, 
2010 
children analysis • Mental 
health 
• Foster 
placement 
Child and 
Adolescent 
Well Being 
rather than 
mental health 
need determine 
prescription 
Steele & 
Buchi, 2008 
6177 
foster 
children 
in Utah 
Database 
analysis 
• Mental 
health 
condition 
• Psychotropic 
use 
• Psychologica
l referrals 
• Mental 
health 
screening 
• Fragmented 
care 
Medical and 
mental health 
evaluation 
Prevalence of 
mental health 
issues and that 
psychotropic 
medication use 
increasing with 
age 
Linares, 
Martinez-
Martin, & 
Castellanos, 
2013 
252 
kids (95 
sibling 
groups) 
in New 
York 
Cohort 
study 
with 
interview
s and 
surveys 
• demographic
s 
• antipsychotic
s and 
stimulants 
• maltreatment 
history 
• psychiatric 
diagnosis 
• metabolic 
effects 
• mental health 
services 
• Evidence 
based 
practice 
 
Caregiver 
and child 
assessments 
correlations 
with 
prescription of 
psychotropics 
and long term 
effects of 
antipsychotics 
Raghavan 
& 
McMillen, 
2008 
403 
foster 
children 
in 
Midwes
tern 
states 
Interview
s 
• Aging out 
• Polypharmac
y 
• Psychotropic 
medication 
use 
• Antipsychoti
cs 
• Mental 
health 
diagnosis 
Interviews 
based on 
DSM IV and 
medication 
audits 
Polypharmacy 
correlates to 
abuse or 
psychiatric 
disorder 
Hayes, 442 Foster • psychotropic Open ended Parents 
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Geiger, & 
Lietz, 2015 
foster 
parents 
parent 
interview 
treatment 
• behavioral 
treatment 
• mental health 
diagnosis 
• Medicaid 
• Continuity of 
care 
• Adjunct 
therapy 
interview 
with foster 
parents 
 
Mental 
health 
therapy and 
medical 
treatment 
satisfied with 
case worker 
intake but 
dissatisfied and 
confuse with 
behavioral 
therapy and 
psychotropic 
therapy 
treatments 
Robst, 
Armstrong, 
& Dollard, 
2011 
1567 
foster 
children 
in 
Florida 
Data 
analysis 
• Treatment 
foster care 
• Treatment 
group care 
• Medicaid 
• Felonies  
Treatment 
foster care 
 
Psychosocial 
and medical 
treatment 
After TFC 
children 
committed less 
felonies- 
treatment 
successful 
Williams & 
Sherr, 2009 
218 
foster 
children 
Interview 
and 
survey 
analysis 
• Medicaid 
• Emotional 
disorders 
• DSM 
diagnosis 
• Foster vs. 
non- foster 
youth 
• Screening 
policy 
Psychosocial 
rehabilitation  
Evidence 
based practice 
and 
psychosocial 
treatment are 
just as 
effective in 
foster youth 
Griffin, 
McClelland
, Holzberg, 
Stolbach, 
Maj, & 
Kisiel, 2011 
14,103 
foster 
children 
CANS 
survey 
• CANS 
decision 
support tool 
• Mental 
health 
symptoms 
• policy 
Mental 
health 
screenings 
and medical 
treatment 
High incidence 
of mental 
health needs 
dosReis, 
Yoon, 
Rubin, 
Riddle, 
Noll, & 
Rothbard, 
2011 
16,969 
in Mid-
Atlantic 
region 
Bivariate 
statistical 
analysis 
based on 
surveys 
• antipsychotic
s 
• psychiatric 
diagnosis 
• lack of 
screening 
Medication 
treatment 
High rate of 
prolonged 
concomitant 
use and need 
for monitoring 
Taussig & 
Culhane, 
2010 
156 
foster 
children 
Randomi
zed 
control 
trial 
• maltreated 
children 
• mental health 
functioning 
• psychiatric 
Mentoring 
and skills 
group- 
“Fostering 
Health 
Skills training 
and mentoring 
effective at 
treating mental 
health 
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symptoms 
• alternative 
treatment 
• adjunct 
therapy 
Futures” 
program 
 
